First-in-human study attacks pancreatic cancer with laser light - UCI Health

“Undruggable.” For decades, that’s what researchers called RAS, the mutation behind about 90 percent of pancreatic cancers. Dr. Brian Wolpin of Dana-Farber Cancer Institute has a different answer: not yet. He shared it yesterday at the MassBioHub, where we hosted our fourth annual Women’s Health Symposium with the Massachusetts Caucus of Women Legislators. This year’s focus was pancreatic cancer, which is personal for this community. The Caucus lost two members to the disease last year, Rep. Ann-Margaret Ferrante and Rep. Carol Doherty.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.